Global Microbial Therapeutic Products Market By Product (GCSF, Peg GCSF, Exenatide, Anti-cancer Agents, Immunosuppressants, Enzymes, and Others), By Route of Administration (Single-use Pre-filled Injection/Injector Pens, Multi-use Injectors, and Others), By Source (Bacteria, and Fungi), By Application (Metabolic Disorders, Hematological Disorders, Oncology, Immunological Disorders, Infectious Diseases, Allergic Diseases, and Others), By End-user (Hospitals, Pharmaceuticals & Biopharmaceutical Companies, and Research & Academic Institutions), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028
Published Date: 08-Feb-2023Healthcare
Category: Report Format : PDF
Report Code: ZMR-6181
Status : Published
The global microbial therapeutic products market was worth USD 63,281.50 million in 2021 and is predicted to reach USD 95,502.24 million by 2028, expanding 7.10% CAGR.